1. A Case of Thrombotic Thrombocytopenia Purpura Associated with Systemic Lupus Erythematosus: Diagnostic Utility of ADAMTS-13 Activity. (15th June 2011) Authors: Yamada, Risa; Nozawa, Kazuhisa; Yoshimine, Takashi; Takasaki, Yoshinari; Ogawa, Hideoki; Takamori, Kenji; Sekigawa, Iwao Other Names: Cervera R. Academic Editor. Journal: Autoimmune diseases Issue: Volume 2011(2011) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A re-evaluation of anti-NA-14 antibodies in patients with primary Sjögren's syndrome: Significant role of interferon-γ in the production of autoantibodies against NA-14. (3rd July 2016) Authors: Uomori, Kaori; Nozawa, Kazuhisa; Ikeda, Keigo; Doe, Kentaro; Yamada, Yusuke; Yamaguchi, Ayako; Fujishiro, Maki; Kawasaki, Mikiko; Morimoto, Shinji; Takamori, Kenji; Sekigawa, Iwao; Chan, Edward K.L.; Takasaki, Yoshinari Journal: Autoimmunity Issue: Volume 49:Number 5(2016) Page Start: 347 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Antibodies to microtubule-associated protein-2 in the cerebrospinal fluid are a useful diagnostic biomarker for neuropsychiatric systemic lupus erythematosus. Issue 4 (3rd July 2016) Authors: Yamada, Yusuke; Nozawa, Kazuhisa; Nakano, Soichiro; Mitsuo, Yukiko; Hiruma, Kaori; Doe, Kentaro; Sekigawa, Iwao; Yamanaka, Kenjiro; Takasaki, Yoshinari Journal: Modern rheumatology Issue: Volume 26:Issue 4(2016) Page Start: 562 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Antiribonuclease H2 antibodies are an immune biomarker for systemic lupus erythematosus. (19th May 2017) Authors: Nozawa, Kazuhisa; Doe, Kentaro; Uomori, Kaori; Sekigawa, Iwao; Takasaki, Yoshinari; Yamaji, Ken; Tamura, Naoto Journal: Autoimmunity Issue: Volume 50:Number 4(2017) Page Start: 241 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Bortezomib treatment prevents glomerulosclerosis associated with lupus nephritis in a murine model through suppressive effects on the immune and renin–angiotensin systems. Issue 1 (2nd January 2017) Authors: Matsuki-Muramoto, Yuko; Nozawa, Kazuhisa; Uomori, Kaori; Sekigawa, Iwao; Takasaki, Yoshinari Journal: Modern rheumatology Issue: Volume 27:Issue 1(2017) Page Start: 77 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Exposure of female NZBWF1 mice to imiquimod-induced lupus nephritis at an early age via a unique mechanism that differed from spontaneous onset. (2nd February 2022) Authors: Hayakawa, Kunihiro; Fujishiro, Maki; Yoshida, Yuko; Kataoka, Yuko; Sakuma, Shota; Nishi, Takuya; Ikeda, Keigo; Morimoto, Shinji; Takamori, Kenji; Sekigawa, Iwao Journal: Clinical and experimental immunology Issue: Volume 208:Number 1(2022) Page Start: 33 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Inhibition of Connective Tissue Growth Factor Ameliorates Disease in a Murine Model of Rheumatoid Arthritis. Issue 6 (30th May 2013) Authors: Nozawa, Kazuhisa; Fujishiro, Maki; Kawasaki, Mikiko; Yamaguchi, Ayako; Ikeda, Keigo; Morimoto, Shinji; Iwabuchi, Kazuhisa; Yanagida, Mitsuaki; Ichinose, Shouzo; Morioka, Megumi; Ogawa, Hideoki; Takamori, Kenji; Takasaki, Yoshinari; Sekigawa, Iwao Journal: Arthritis and rheumatism Issue: Volume 65:Issue 6(2013:Jun.) Page Start: 1477 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Inhibition of Connective Tissue Growth Factor Ameliorates Disease in a Murine Model of Rheumatoid Arthritis. Issue 6 (30th May 2013) Authors: Nozawa, Kazuhisa; Fujishiro, Maki; Kawasaki, Mikiko; Yamaguchi, Ayako; Ikeda, Keigo; Morimoto, Shinji; Iwabuchi, Kazuhisa; Yanagida, Mitsuaki; Ichinose, Shouzo; Morioka, Megumi; Ogawa, Hideoki; Takamori, Kenji; Takasaki, Yoshinari; Sekigawa, Iwao Journal: Arthritis and rheumatism Issue: Volume 65:Issue 6(2013:Jun.) Page Start: 1477 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Inhibition of each module of connective tissue growth factor as a potential therapeutic target for rheumatoid arthritis. (17th February 2016) Authors: Miyashita, Tomoko; Morimoto, Shinji; Fujishiro, Maki; Hayakawa, Kunihiro; Suzuki, Satoshi; Ikeda, Keigo; Miyazawa, Keiji; Morioka, Megumi; Takamori, Kenji; Ogawa, Hideoki; Sekigawa, Iwao; Takasaki, Yoshinari Journal: Autoimmunity Issue: Volume 49:Number 2(2016) Page Start: 109 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Inhibition of the insulin-like growth factor system is a potential therapy for rheumatoid arthritis. (June 2015) Authors: Suzuki, Satoshi; Morimoto, Shinji; Fujishiro, Maki; Kawasaki, Mikiko; Hayakawa, Kunihiro; Miyashita, Tomoko; Ikeda, Keigo; Miyazawa, Keiji; Yanagida, Mitsuaki; Takamori, Kenji; Ogawa, Hideoki; Sekigawa, Iwao; Takasaki, Yoshinari Journal: Autoimmunity Issue: Volume 48:Number 4(2015) Page Start: 251 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗